181 related articles for article (PubMed ID: 32233147)
1. Clinical Results of Various Treatments for Retinal Capillary Hemangioma.
Won YK; Lee MW; Shin YI; Kim JY; Jo YJ
Korean J Ophthalmol; 2020 Apr; 34(2):133-142. PubMed ID: 32233147
[TBL] [Abstract][Full Text] [Related]
2. Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.
Tsai FY; Lau LI; Chen SJ; Lee FL; Lee SM
J Chin Med Assoc; 2014 Jan; 77(1):52-6. PubMed ID: 24206762
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.
Agarwal A; Kumari N; Singh R
Int Ophthalmol; 2016 Oct; 36(5):747-50. PubMed ID: 26815929
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
5. INTRAVITREAL INJECTION OF PROPRANOLOL FOR THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMA IN A CASE OF VON HIPPEL-LINDAU.
Karimi S; Nikkhah H; Ahmadieh H; Safi S
Retin Cases Brief Rep; 2020; 14(4):305-309. PubMed ID: 29466252
[TBL] [Abstract][Full Text] [Related]
6. Atypical Exophytic Retinal Capillary Hemangioma and Diagnostic Modalities.
Shechtman DL; Gold AS; McIntosh S; Steen J; Murray TG
Optom Vis Sci; 2016 Jan; 93(1):107-12. PubMed ID: 26583797
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Therapeutic Outcomes of Photodynamic Therapy-Based or Photocoagulation-Based Treatments on Retinal Capillary Hemangioma.
Huang C; Tian Z; Lai K; Zhong X; Zhou L; Xu F; Yang H; Lu L; Jin C
Photomed Laser Surg; 2018 Jan; 36(1):10-17. PubMed ID: 29068750
[TBL] [Abstract][Full Text] [Related]
8. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S; Meyer CH; Callizo J
Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
[TBL] [Abstract][Full Text] [Related]
9. SPONTANEOUS RESOLUTION OF MACULAR EPIRETINAL MEMBRANES AFTER FLUORESCEIN POTENTIATED ARGON LASER TREATMENT OF VON HIPPEL-LINDAU ASSOCIATED RETINAL HEMANGIOMAS: CASE REPORT AND REVIEW OF LITERATURE.
Kolomeyer AM; Eller AW; Martel JN
Retin Cases Brief Rep; 2016; 10(2):145-50. PubMed ID: 26421964
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for retinal capillary hemangioma.
Papastefanou VP; Pilli S; Stinghe A; Lotery AJ; Cohen VM
Eye (Lond); 2013 Mar; 27(3):438-42. PubMed ID: 23288135
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal Triamcinolone Acetonide in Von Hippel-Lindau Patient with Novel Mutation.
Bunajem M; Magliyah M; Alzahrani Y
Middle East Afr J Ophthalmol; 2020; 27(3):188-190. PubMed ID: 33488018
[TBL] [Abstract][Full Text] [Related]
12. Massive exudative retinal detachment following photodynamic therapy and intravitreal bevacizumab injection in retinal capillary hemangioma.
Kim HM; Park KH; Woo SJ
Korean J Ophthalmol; 2015 Apr; 29(2):143-5. PubMed ID: 25829835
[No Abstract] [Full Text] [Related]
13. Combined therapy guided by multimodal imaging of fifteen retinal capillary hemangioblastomas in a monocular Von Hippel- Lindau syndrome case report.
Guo J; Du L; Zhou P; Guo X; Dai F; Jin X
BMC Ophthalmol; 2022 May; 22(1):205. PubMed ID: 35524216
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
Dahr SS; Cusick M; Rodriguez-Coleman H; Srivastava SK; Thompson DJ; Linehan WM; Ferris FL; Chew EY
Retina; 2007 Feb; 27(2):150-8. PubMed ID: 17290195
[TBL] [Abstract][Full Text] [Related]
16. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
17. PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION: A Randomized Double-Masked Controlled Clinical Trial.
Nourinia R; Emamverdi M; Ramezani A; Amizadeh Y; Khorshidifar M; Behnaz N; Safi S
Retina; 2020 Jun; 40(6):1110-1117. PubMed ID: 31157710
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography angiography in assessment of response to therapy in retinal capillary hemangioblastoma and diffuse choroidal hemangioma.
Sagar P; Shanmugam PM; Konana VK; Ramanjulu R; Mishra KCD; Simakurthy S
Indian J Ophthalmol; 2019 May; 67(5):701-703. PubMed ID: 31007251
[TBL] [Abstract][Full Text] [Related]
19. CLINICALLY INVISIBLE RETINAL HEMANGIOBLASTOMAS DETECTED BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AND FLUORESCEIN ANGIOGRAPHY IN TWINS.
Schoen MA; Shields CL; Say EAT; Douglass AM; Shields JA; Jampol LM
Retin Cases Brief Rep; 2018 Winter; 12(1):12-16. PubMed ID: 27533642
[TBL] [Abstract][Full Text] [Related]
20. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Song JH; Park A; Kim MH
Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
